CIK 0001768446 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Climb Bio, Inc.
Sign in to watch- Ticker
- CLYM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 832273741
- Phone
- 1-866-857-2596
- Business address
- 20 WILLIAM STREET, SUITE G50, WELLESLEY HILLS, MA
- Former names
- Eliem Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,366,820
- in 1 filing, $1.4M under 10b5-1 plans
Net −$1,366,820. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-15 | Thomas Stephen Basil Director | Sale 10b5-1 | −100,000 | $13.67 | $1.4M | 467,969 |
| 2026-06-05 | Thomas Stephen Basil Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2026-02-26 | Thomas Stephen Basil Director | Sale 10b5-1 | −16,313 | $7.01 | $114K | 154,657 |
| 2026-02-25 | Thomas Stephen Basil Director | Sale 10b5-1 | −33,687 | $7.00 | $236K | 170,970 |
| 2026-02-13 | Thomas Stephen Basil Director | Sale 10b5-1 | −10,000 | $5.81 | $58K | 204,657 |
| 2026-02-12 | Thomas Stephen Basil Director | Sale 10b5-1 | −90,000 | $5.23 | $471K | 214,657 |
| 2025-08-07 | Thomas Stephen Basil Director | Grant or award | +100,375 | 304,657 | ||
| 2025-06-27 | Thomas Stephen Basil Director | Option exercise | +25,094 | 204,282 | ||
| 2025-06-27 | Thomas Stephen Basil Director | Option exercise · Restricted Stock Units | −25,094 | 0 | ||
| 2025-06-04 | Thomas Stephen Basil Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2025-03-27 | Thomas Stephen Basil Director | Option exercise | +25,093 | 179,188 | ||
| 2025-03-27 | Thomas Stephen Basil Director | Option exercise · Restricted Stock Units | −25,093 | 25,094 | ||
| 2025-01-01 | Thomas Stephen Basil Director | Option exercise | +50,188 | 154,095 | ||
| 2025-01-01 | Thomas Stephen Basil Director | Option exercise · Restricted Stock Units | −50,188 | 50,187 | ||
| 2024-06-27 | Thomas Stephen Basil Director | Grant or award | +103,907 | 103,907 | ||
| 2024-06-27 | Thomas Stephen Basil Director | Grant or award · Restricted Stock Units | +100,375 | 100,375 |
Page 1 of 1 · 16 trades